April 22, 2013
GeneFrontier Corporation, a Japan-based biotech company (hereinafter referred to as GFC) announced today the signature with the Japanese public company of the alliance regarding its proprietary technology, “PUREfrex RD.” This is the second deal with PUREfrex RD this year.